Abnormal methylation of the sex-determining region Y-box 17 (SOX17) promoter predicts poor prognosis in myelodysplastic syndrome

Clinical Laboratory

Volumn 60, Issue 9, 2014, Pages 1465-1474

  Fan, Rong ^a   Zhao, Xiao Li ^b   Wang, Hong ^c   He, Hai Yan ^a   Peng, Zhen Ping ^a   Yang, Bo ^d   Han, Tao ^d   Wang, Wei ^b   Wang, Xiao Qin ^b   Lin, Guo Wei ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c SOOCHOW UNIVERSITY   (China)

^d Fudan Cinpathogen Clinical and Molecular Research Center   (China)

Author keywords

MDS; Methylation; Prognosis; SOX17 gene

Indexed keywords

MESSENGER RNA; SEX DETERMINING REGION Y PROTEIN 17; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; SOX17 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE SILENCING; HEMATOLOGICAL PARAMETERS; HUMAN; INTERNATIONAL PROGNOSTIC SCORING SYSTEM; MAJOR CLINICAL STUDY; MALE; METHYLATION; MULTIVARIATE ANALYSIS; MYELODYSPLASTIC SYNDROME; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGION; UPREGULATION; WORLD HEALTH ORGANIZATION; ADOLESCENT; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; DISEASE COURSE; DNA METHYLATION; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; PHENOTYPE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; TIME; TUMOR CELL LINE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; DNA METHYLATION; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYELODYSPLASTIC SYNDROMES; PHENOTYPE; PROGNOSIS; PROMOTER REGIONS, GENETIC; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; RNA, MESSENGER; SOXF TRANSCRIPTION FACTORS; TIME FACTORS; UP-REGULATION; YOUNG ADULT;

EID: 84908110095     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2013.130414     Document Type: Article

References (34)

1. Heaney ML, Golde DW. Myelodysplasia. N Engl J Med 1999; 340: 1649-60.
2. Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes. Blood 2009;114: 937-51.
3. Watanabe Y, Maekawa M. Methylation of DNA in cancer. Adv Clin Chem 2010;52: 145-67.
4. Hatziapostolou M, Iliopoulos D. Epigenetic aberrations during oncogenesis. Cell Mol Life Sci 2011;68: 1681-702.
5. Aggerholm A, Holm MS, Guldberg P, Olesen LH, Hokland P. Promoter hypermethylation of pl5INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients. Eur J Haematol 2006;76: 23-32.
6. Tien HF, Tang JH, Tsay W, et al. Methylation of the pi 5(INK4B) gene in myelodysplastic syndrome: It can be detected early at diagnosis or during disease progression and is highly associated with leukaemic transformation. Br J Haematol 2001 ; 112: 148-54.
7. Wang H, Wang XQ, Xu XP, Lin GW. ID4 methylation predicts high risk of leukemic transformation in patients with myelodysplastic syndrome. Leuk Res 2010;34: 598-604.
8. Bowles J, Schepers G, Koopman P. Phytogeny of the SOX family of developmental transcription factors based on sequence and structural indicators. Developmental Biology 2000;227: 239-55.
9. Sohn J, Natale J, Chew LJ, et al. Identification of Soxl7 as a transcription factor that regulates oligodendrocyte development. Journal of Neuroscience 2006;26: 9722-35.
10. Francois M, Koopman P, Beltrame M. SoxF genes: Key players in the development of the cardio-vascular system. Int J Biochem Cell Biol 2010;42: 445-8.
11. Sakamoto Y, Hara K, Kanai-Azuma M, et al. Redundant roles of Sox 17 and Sox 18 in early cardiovascular development of mouse embryos. Biochemical and Biophysical Research Communications 2007;360: 539-44.
12. Van Hoof D, Mendelsohn AD, Seerke R, Desai TA, German MS. Differentiation of human embryonic stem cells into pancreatic endoderm in patterned size-controlled clusters. Stem Cell Res 2011; 6: 276-85.
13. Serrano AG, Gandillet A, Pearson S, Lacaud G, Kouskoff V. Contrasting effects of Sox 17- and Soxl8-sustained expression at the onset of blood specification. Blood 2010;115: 3895-8.
14. Jia Y, Yang Y, Liu S, Herman JG, Lu F, Guo M. SOX 17 antagonizes WNT/beta-catenin signaling pathway in hepatocellular carcinoma. Epigenetics 2010;5: 743-9.
15. Chimonidou M, Strati A, Tzitzira A, et al. DNA methylation of tumor suppressor and metastasis suppressor genes in circulating tumor cells. Clin Chem 2011 ;57: 1169-77.
16. Mulholland DJ, Dedhar S, Coetzee GA, Nelson CC. Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know? Endocr Rev 2005;26: 898-915.
17. Sinner D, Kordich JJ, Spence JR, et al. Sox 17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells. Mol Cell Biol 2007;27: 7802-15.
18. Zhang W, Glockner SC, Guo M, et al. Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer. Cancer Res 2008;68: 2764-72.
19. van der Meide WF, Snellenberg S, Meijer CJ, et al. Promoter methylation analysis of WNT/beta-catenin signaling pathway regulators to detect adenocarcinoma or its precursor lesion of the cervix. Gynecol Oncol 2011;123(1): 116-22.
20. Du YC, Oshima H, Oguma K, et al. Induction and down-regulation of Soxl7 and its possible roles during the course of gastrointestinal tumorigenesis. Gastroenterology 2009;137: 1346-57.
21. Fu DY, Wang ZM, Chen L, et al. Soxl7, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer. Breast Cancer Res Treat 2010;119: 601-12.
22. Griffiths EA, Gore SD, Hooker CM, et al. Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation. Leuk Lymphoma 2010;51: 1711-9.
23. Wang H, Wang X, Xu X, Lin G. Mean corpuscular volume predicts prognosis in MDS patients with abnormal karyotypes. Ann Hematol 2010;89: 671-9.
24. Yasunaga M, Tada S, Torikai-Nishikawa S, et al. Induction and monitoring of definitive and visceral endoderm differentiation of mouse ES cells. Nat Biotechnol 2005;23: 1542-50.
25. Wang P, Rodriguez RT, Wang J, Ghodasara A, Kim SK. Targeting SOX17 in human embryonic stem cells creates unique strategies for isolating and analyzing developing endoderm. Cell Stem Cell 2011;8: 335-46.
26. Kohno H, Amatya VJ, Takeshima Y, et al. Aberrant promoter methylation of WIF-1 and SFRP1, 2, 4 genes in mesothelioma. Oncol Rep 2010;24: 423-31.
27. Suehiro Y, Wong CW, Chirieac LR, et al. Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma. Clin Cancer Res 2008;14: 2560-9.
28. Lin YW, Chung MT, Lai HC, et al. Methylation analysis of SFRP genes family in cervical adenocarcinoma. J Cancer Res Clin Oncol 2009;135: 1665-74.
29. Jost E, Schmid J, Wilop S, et al. Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia. Br J Haematol 2008;142: 745-53.
30. Figueroa ME, Skrabanek L, Li Y, et al. MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation. Blood 2009;114: 3448-58.
31. Valencia A, Roman-Gomez J, Cervera J, et al. Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia. Leukemia 2009;23: 1658-66.
32. Jost E, Schmid J, Wilop S, et al. Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia. Br J Haematol 2008;142: 745-53.
33. Suzuki R, Onizuka M, Kojima M, et al. Preferential hypermethy-lation of the Dickkopf-1 promoter in core-binding factor leukaemia. Br J Haematol 2007;138: 624-31.
34. He S, Kim I, Lim MS, Morrison SJ. Soxl7 expression confers self-renewal potential and fetal stem cell characteristics upon adult hematopoietic progenitors. Genes Dev 2011 ;25: 1613-27.